| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
16,745 |
14,856 |
$1.58M |
| A4649 |
Surgical supply; miscellaneous |
4,019 |
3,450 |
$1.57M |
| J3490 |
Unclassified drugs |
5,704 |
4,255 |
$862K |
| 36415 |
Collection of venous blood by venipuncture |
5,008 |
4,377 |
$595K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
927 |
908 |
$231K |
| 80053 |
Comprehensive metabolic panel |
6,639 |
5,913 |
$193K |
| 71046 |
Radiologic examination, chest; 2 views |
1,734 |
1,707 |
$95K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
790 |
739 |
$90K |
| 87081 |
|
723 |
716 |
$83K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
896 |
887 |
$67K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
408 |
397 |
$66K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,323 |
1,030 |
$64K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,568 |
1,401 |
$46K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
590 |
518 |
$46K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,051 |
956 |
$42K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
474 |
219 |
$39K |
| 70450 |
Computed tomography, head or brain; without contrast material |
952 |
924 |
$39K |
| 71045 |
Radiologic examination, chest; single view |
2,071 |
1,991 |
$39K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
725 |
711 |
$37K |
| 81001 |
|
3,148 |
2,976 |
$33K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,542 |
1,487 |
$33K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
477 |
469 |
$30K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,790 |
1,635 |
$27K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
168 |
163 |
$26K |
| J2060 |
Injection, lorazepam, 2 mg |
241 |
217 |
$23K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
986 |
944 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
450 |
427 |
$21K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
165 |
153 |
$19K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
244 |
200 |
$18K |
| 87077 |
|
346 |
341 |
$17K |
| 73630 |
|
194 |
191 |
$17K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
678 |
670 |
$15K |
| 81002 |
|
737 |
710 |
$15K |
| 81025 |
|
1,306 |
1,263 |
$15K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
400 |
370 |
$13K |
| 82962 |
|
833 |
444 |
$13K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
707 |
649 |
$12K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
483 |
450 |
$11K |
| 81000 |
|
651 |
643 |
$10K |
| 11043 |
|
49 |
25 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,246 |
1,131 |
$8K |
| 73562 |
|
94 |
93 |
$8K |
| 73130 |
|
67 |
67 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,492 |
1,370 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,347 |
6,395 |
$7K |
| 73030 |
|
73 |
71 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,401 |
3,129 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
754 |
667 |
$6K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
315 |
292 |
$6K |
| 73610 |
|
62 |
61 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
493 |
482 |
$4K |
| 86850 |
|
95 |
95 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
742 |
735 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,622 |
1,428 |
$4K |
| 0710 |
|
77 |
75 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
102 |
92 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
148 |
147 |
$3K |
| 73110 |
|
40 |
40 |
$3K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
151 |
146 |
$3K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
13 |
13 |
$3K |
| 90715 |
|
12 |
12 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
35 |
35 |
$2K |
| 76830 |
Ultrasound, transvaginal |
80 |
80 |
$2K |
| 84702 |
|
643 |
617 |
$2K |
| 86900 |
|
198 |
196 |
$2K |
| 83880 |
|
1,068 |
993 |
$2K |
| 72100 |
|
13 |
13 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
16 |
16 |
$1K |
| 84703 |
|
898 |
861 |
$1K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$1K |
| 0761 |
|
29 |
25 |
$1K |
| 0250 |
|
14 |
12 |
$1K |
| 87070 |
|
27 |
27 |
$1K |
| 83690 |
|
3,130 |
2,875 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
337 |
327 |
$990.35 |
| 84484 |
|
1,916 |
1,722 |
$984.87 |
| 85610 |
|
932 |
881 |
$849.53 |
| 85379 |
|
303 |
295 |
$820.79 |
| 83605 |
|
817 |
761 |
$736.87 |
| 87186 |
|
298 |
294 |
$631.67 |
| A9270 |
Non-covered item or service |
598 |
487 |
$530.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$518.13 |
| 87634 |
|
269 |
265 |
$493.58 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
82 |
82 |
$451.07 |
| 85730 |
|
702 |
670 |
$422.74 |
| 87040 |
|
549 |
521 |
$378.29 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12 |
12 |
$337.68 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
94 |
88 |
$280.93 |
| 96376 |
|
333 |
275 |
$275.40 |
| 83735 |
|
338 |
289 |
$161.40 |
| 82550 |
|
685 |
676 |
$137.33 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$87.97 |
| 86703 |
|
105 |
102 |
$84.57 |
| 85027 |
|
173 |
162 |
$84.31 |
| 86140 |
|
57 |
57 |
$80.38 |
| 87205 |
|
37 |
36 |
$60.44 |
| 86901 |
|
199 |
197 |
$29.03 |
| 94760 |
|
37 |
27 |
$20.43 |
| 80076 |
|
27 |
27 |
$7.32 |
| 85007 |
|
75 |
68 |
$7.12 |
| 82553 |
|
12 |
12 |
$0.00 |
| 87807 |
|
14 |
14 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$0.00 |